Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 253 to 264 of 264 entries
Sorted by: Best Match Show Resources per page
Optimization of a Multi-Product Intra-Supply Chain System with Failure in Rework.

PloS one

Chiu SW, Chen SW, Chang CK, Chiu YP.
PMID: 27918588
PLoS One. 2016 Dec 05;11(12):e0167511. doi: 10.1371/journal.pone.0167511. eCollection 2016.

Globalization has created tremendous opportunities, but also made business environment highly competitive and turbulent. To gain competitive advantage, management of present-day transnational firms always seeks options to trim down various transaction and coordination costs, especially in the area of...

Cite
Chiu SW, Chen SW, Chang CK, et al. Optimization of a Multi-Product Intra-Supply Chain System with Failure in Rework. PLoS One. 2016;11(12):e0167511doi: 10.1371/journal.pone.0167511.
Chiu, S. W., Chen, S. W., Chang, C. K., & Chiu, Y. P. (2016). Optimization of a Multi-Product Intra-Supply Chain System with Failure in Rework. PloS one, 11(12), e0167511. https://doi.org/10.1371/journal.pone.0167511
Chiu, Singa Wang, et al. "Optimization of a Multi-Product Intra-Supply Chain System with Failure in Rework." PloS one vol. 11,12 (2016): e0167511. doi: https://doi.org/10.1371/journal.pone.0167511
Chiu SW, Chen SW, Chang CK, Chiu YP. Optimization of a Multi-Product Intra-Supply Chain System with Failure in Rework. PLoS One. 2016 Dec 05;11(12):e0167511. doi: 10.1371/journal.pone.0167511. eCollection 2016. PMID: 27918588; PMCID: PMC5137895.
Copy Download .nbib Format: NLM
23andMe and the FDA.

The New England journal of medicine

Annas GJ, Elias S.
PMID: 24897100
N Engl J Med. 2014 Jun 05;370(23):2248-9. doi: 10.1056/NEJMc1404692.

No abstract available.

Cite
Annas GJ, Elias S. 23andMe and the FDA. N Engl J Med. 2014;370(23):2248-9doi: 10.1056/NEJMc1404692.
Annas, G. J., & Elias, S. (2014). 23andMe and the FDA. The New England journal of medicine, 370(23), 2248-9. https://doi.org/10.1056/NEJMc1404692
Annas, George J, and Elias, Sherman. "23andMe and the FDA." The New England journal of medicine vol. 370,23 (2014): 2248-9. doi: https://doi.org/10.1056/NEJMc1404692
Annas GJ, Elias S. 23andMe and the FDA. N Engl J Med. 2014 Jun 05;370(23):2248-9. doi: 10.1056/NEJMc1404692. PMID: 24897100.
Copy Download .nbib Format: NLM
23andMe and the FDA.

The New England journal of medicine

Yuji K, Tanimoto T, Oshima Y.
PMID: 24897101
N Engl J Med. 2014 Jun 05;370(23):2248. doi: 10.1056/NEJMc1404692.

No abstract available.

Cite
Yuji K, Tanimoto T, Oshima Y. 23andMe and the FDA. N Engl J Med. 2014;370(23):2248doi: 10.1056/NEJMc1404692.
Yuji, K., Tanimoto, T., & Oshima, Y. (2014). 23andMe and the FDA. The New England journal of medicine, 370(23), 2248. https://doi.org/10.1056/NEJMc1404692
Yuji, Koichiro, et al. "23andMe and the FDA." The New England journal of medicine vol. 370,23 (2014): 2248. doi: https://doi.org/10.1056/NEJMc1404692
Yuji K, Tanimoto T, Oshima Y. 23andMe and the FDA. N Engl J Med. 2014 Jun 05;370(23):2248. doi: 10.1056/NEJMc1404692. PMID: 24897101.
Copy Download .nbib Format: NLM
23andMe Paves the Way for Direct-to-Consumer Genetic Health Risk Tests of Limited Clinical Utility.

Annals of internal medicine

Wynn J, Chung WK.
PMID: 28554190
Ann Intern Med. 2017 Jul 18;167(2):125-126. doi: 10.7326/M17-1045. Epub 2017 May 30.

No abstract available.

Cite
Wynn J, Chung WK. 23andMe Paves the Way for Direct-to-Consumer Genetic Health Risk Tests of Limited Clinical Utility. Ann Intern Med. 2017;167(2):125-126doi: 10.7326/M17-1045.
Wynn, J., & Chung, W. K. (2017). 23andMe Paves the Way for Direct-to-Consumer Genetic Health Risk Tests of Limited Clinical Utility. Annals of internal medicine, 167(2), 125-126. https://doi.org/10.7326/M17-1045
Wynn, Julia, and Chung, Wendy K. "23andMe Paves the Way for Direct-to-Consumer Genetic Health Risk Tests of Limited Clinical Utility." Annals of internal medicine vol. 167,2 (2017): 125-126. doi: https://doi.org/10.7326/M17-1045
Wynn J, Chung WK. 23andMe Paves the Way for Direct-to-Consumer Genetic Health Risk Tests of Limited Clinical Utility. Ann Intern Med. 2017 Jul 18;167(2):125-126. doi: 10.7326/M17-1045. Epub 2017 May 30. PMID: 28554190.
Copy Download .nbib Format: NLM
Psychology of word of mouth marketing.

Current opinion in psychology

Chen Z, Yuan M.
PMID: 31377578
Curr Opin Psychol. 2020 Feb;31:7-10. doi: 10.1016/j.copsyc.2019.06.026. Epub 2019 Jul 02.

Given the importance of online word of mouth (WOM), there has been an increasing need to understand the psychological mechanisms that underlie WOM transmission (i.e. sharing of opinions) and reception (i.e. processing of received messages). The goal of the...

Cite
Chen Z, Yuan M. Psychology of word of mouth marketing. Curr Opin Psychol. 2019;31:7-10doi: 10.1016/j.copsyc.2019.06.026.
Chen, Z., & Yuan, M. (2020). Psychology of word of mouth marketing. Current opinion in psychology, 317-10. https://doi.org/10.1016/j.copsyc.2019.06.026
Chen, Zoey, and Yuan, May. "Psychology of word of mouth marketing." Current opinion in psychology vol. 31 (2020): 7-10. doi: https://doi.org/10.1016/j.copsyc.2019.06.026
Chen Z, Yuan M. Psychology of word of mouth marketing. Curr Opin Psychol. 2020 Feb;31:7-10. doi: 10.1016/j.copsyc.2019.06.026. Epub 2019 Jul 02. PMID: 31377578.
Copy Download .nbib Format: NLM
Post-marketing safety signals: Challenges in regulatory decisions, communication & impact evaluation in developing countries.

The Indian journal of medical research

Kshirsagar N.
PMID: 29434057
Indian J Med Res. 2017 Oct;146(4):445-447. doi: 10.4103/ijmr.IJMR_1070_17.

No abstract available.

Cite
Kshirsagar N. Post-marketing safety signals: Challenges in regulatory decisions, communication & impact evaluation in developing countries. Indian J Med Res. 2017;146(4):445-447doi: 10.4103/ijmr.IJMR_1070_17.
Kshirsagar, N. (2017). Post-marketing safety signals: Challenges in regulatory decisions, communication & impact evaluation in developing countries. The Indian journal of medical research, 146(4), 445-447. https://doi.org/10.4103/ijmr.IJMR_1070_17
Kshirsagar, Nilima. "Post-marketing safety signals: Challenges in regulatory decisions, communication & impact evaluation in developing countries." The Indian journal of medical research vol. 146,4 (2017): 445-447. doi: https://doi.org/10.4103/ijmr.IJMR_1070_17
Kshirsagar N. Post-marketing safety signals: Challenges in regulatory decisions, communication & impact evaluation in developing countries. Indian J Med Res. 2017 Oct;146(4):445-447. doi: 10.4103/ijmr.IJMR_1070_17. PMID: 29434057; PMCID: PMC5819025.
Copy Download .nbib Format: NLM
Multi-perspective neural architecture for recommendation system.

Neural networks : the official journal of the International Neural Network Society

Xiao H, Chen Y, Shi X, Xu G.
PMID: 31326662
Neural Netw. 2019 Oct;118:280-288. doi: 10.1016/j.neunet.2019.06.007. Epub 2019 Jun 27.

Currently, there starts a research trend to leverage neural architecture for recommendation systems. Though several deep recommender models are proposed, most methods are too simple to characterize users' complex preference. In this paper, for a fine-grained analysis, users' ratings...

Cite
Xiao H, Chen Y, Shi X, et al. Multi-perspective neural architecture for recommendation system. Neural Netw. 2019;118:280-288doi: 10.1016/j.neunet.2019.06.007.
Xiao, H., Chen, Y., Shi, X., & Xu, G. (2019). Multi-perspective neural architecture for recommendation system. Neural networks : the official journal of the International Neural Network Society, 118280-288. https://doi.org/10.1016/j.neunet.2019.06.007
Xiao, Han, et al. "Multi-perspective neural architecture for recommendation system." Neural networks : the official journal of the International Neural Network Society vol. 118 (2019): 280-288. doi: https://doi.org/10.1016/j.neunet.2019.06.007
Xiao H, Chen Y, Shi X, Xu G. Multi-perspective neural architecture for recommendation system. Neural Netw. 2019 Oct;118:280-288. doi: 10.1016/j.neunet.2019.06.007. Epub 2019 Jun 27. PMID: 31326662.
Copy Download .nbib Format: NLM
The power of prediction markets.

Nature

Mann A.
PMID: 27762382
Nature. 2016 Oct 20;538(7625):308-310. doi: 10.1038/538308a.

No abstract available.

Cite
Mann A. The power of prediction markets. Nature. 2016;538(7625):308-310doi: 10.1038/538308a.
Mann, A. (2016). The power of prediction markets. Nature, 538(7625), 308-310. https://doi.org/10.1038/538308a
Mann, Adam. "The power of prediction markets." Nature vol. 538,7625 (2016): 308-310. doi: https://doi.org/10.1038/538308a
Mann A. The power of prediction markets. Nature. 2016 Oct 20;538(7625):308-310. doi: 10.1038/538308a. PMID: 27762382.
Copy Download .nbib Format: NLM
Quality Issues Identified During the Evaluation of Biosimilars by the European Medicines Agency's Committee for Medicinal Products for Human Use.

AAPS PharmSciTech

Cilia M, Ruiz S, Richardson P, Salmonson T, Serracino-Inglott A, Wirth F, Borg JJ.
PMID: 29027130
AAPS PharmSciTech. 2018 Feb;19(2):489-511. doi: 10.1208/s12249-017-0892-0. Epub 2017 Oct 12.

The aim of this study was to identify trends in deficiencies raised during the EU evaluation of the quality part of dossiers for marketing authorisation applications of biosimilar medicinal products. All adopted day 120 list of questions on the...

Cite
Cilia M, Ruiz S, Richardson P, et al. Quality Issues Identified During the Evaluation of Biosimilars by the European Medicines Agency's Committee for Medicinal Products for Human Use. AAPS PharmSciTech. 2017;19(2):489-511doi: 10.1208/s12249-017-0892-0.
Cilia, M., Ruiz, S., Richardson, P., Salmonson, T., Serracino-Inglott, A., Wirth, F., & Borg, J. J. (2018). Quality Issues Identified During the Evaluation of Biosimilars by the European Medicines Agency's Committee for Medicinal Products for Human Use. AAPS PharmSciTech, 19(2), 489-511. https://doi.org/10.1208/s12249-017-0892-0
Cilia, Mark, et al. "Quality Issues Identified During the Evaluation of Biosimilars by the European Medicines Agency's Committee for Medicinal Products for Human Use." AAPS PharmSciTech vol. 19,2 (2018): 489-511. doi: https://doi.org/10.1208/s12249-017-0892-0
Cilia M, Ruiz S, Richardson P, Salmonson T, Serracino-Inglott A, Wirth F, Borg JJ. Quality Issues Identified During the Evaluation of Biosimilars by the European Medicines Agency's Committee for Medicinal Products for Human Use. AAPS PharmSciTech. 2018 Feb;19(2):489-511. doi: 10.1208/s12249-017-0892-0. Epub 2017 Oct 12. PMID: 29027130.
Copy Download .nbib Format: NLM
Junk food consumption trends point to the need for retail policies.

The American journal of clinical nutrition

Jensen ML, Schwartz MB.
PMID: 34236389
Am J Clin Nutr. 2021 Sep 01;114(3):837-838. doi: 10.1093/ajcn/nqab189.

No abstract available.

Cite
Jensen ML, Schwartz MB. Junk food consumption trends point to the need for retail policies. Am J Clin Nutr. 2021;114(3):837-838doi: 10.1093/ajcn/nqab189.
Jensen, M. L., & Schwartz, M. B. (2021). Junk food consumption trends point to the need for retail policies. The American journal of clinical nutrition, 114(3), 837-838. https://doi.org/10.1093/ajcn/nqab189
Jensen, Melissa L, and Schwartz, Marlene B. "Junk food consumption trends point to the need for retail policies." The American journal of clinical nutrition vol. 114,3 (2021): 837-838. doi: https://doi.org/10.1093/ajcn/nqab189
Jensen ML, Schwartz MB. Junk food consumption trends point to the need for retail policies. Am J Clin Nutr. 2021 Sep 01;114(3):837-838. doi: 10.1093/ajcn/nqab189. PMID: 34236389.
Copy Download .nbib Format: NLM
Nursing work environment, professional self-actualization and marketing of the nursing profession: Cross-sectional study.

Nursing open

Hazanov Y, Gehman Y, Wilf Miron R, Kagan I.
PMID: 33318851
Nurs Open. 2020 Oct 03;8(1):434-441. doi: 10.1002/nop2.644. eCollection 2021 Jan.

AIM: To explore associations between nurses' sense of professional self-actualization, nursing work environment and their involvement in promotion and marketing of the nursing profession.DESIGN: A descriptive cross-sectional study.METHODS: 144 nurses from various clinical fields completed a promotion and marketing...

Cite
Hazanov Y, Gehman Y, Wilf Miron R, et al. Nursing work environment, professional self-actualization and marketing of the nursing profession: Cross-sectional study. Nurs Open. 2020;8(1):434-441doi: 10.1002/nop2.644.
Hazanov, Y., Gehman, Y., Wilf Miron, R., & Kagan, I. (2021). Nursing work environment, professional self-actualization and marketing of the nursing profession: Cross-sectional study. Nursing open, 8(1), 434-441. https://doi.org/10.1002/nop2.644
Hazanov, Yelena, et al. "Nursing work environment, professional self-actualization and marketing of the nursing profession: Cross-sectional study." Nursing open vol. 8,1 (2021): 434-441. doi: https://doi.org/10.1002/nop2.644
Hazanov Y, Gehman Y, Wilf Miron R, Kagan I. Nursing work environment, professional self-actualization and marketing of the nursing profession: Cross-sectional study. Nurs Open. 2020 Oct 03;8(1):434-441. doi: 10.1002/nop2.644. eCollection 2021 Jan. PMID: 33318851; PMCID: PMC7729788.
Copy Download .nbib Format: NLM
Rewarding innovation in drug discovery.

Health affairs (Project Hope)

Lopes G.
PMID: 19414906
Health Aff (Millwood). 2009 May-Jun;28(3):922-3. doi: 10.1377/hlthaff.28.3.922-a.

No abstract available.

Cite
Lopes G. Rewarding innovation in drug discovery. Health Aff (Millwood). 2009;28(3):922-3doi: 10.1377/hlthaff.28.3.922-a.
Lopes, G. (2009). Rewarding innovation in drug discovery. Health affairs (Project Hope), 28(3), 922-3. https://doi.org/10.1377/hlthaff.28.3.922-a
Lopes, Gilberto. "Rewarding innovation in drug discovery." Health affairs (Project Hope) vol. 28,3 (2009): 922-3. doi: https://doi.org/10.1377/hlthaff.28.3.922-a
Lopes G. Rewarding innovation in drug discovery. Health Aff (Millwood). 2009 May-Jun;28(3):922-3. doi: 10.1377/hlthaff.28.3.922-a. PMID: 19414906.
Copy Download .nbib Format: NLM
Showing 253 to 264 of 264 entries